Hepatitis C virus infection: a risk factor for Parkinson's disease
- PMID: 25608223
- DOI: 10.1111/jvh.12392
Hepatitis C virus infection: a risk factor for Parkinson's disease
Abstract
Recent studies found that hepatitis C virus (HCV) may invade the central nervous system, and both HCV and Parkinson's disease (PD) have in common the overexpression of inflammatory biomarkers. We analysed data from a community-based integrated screening programme based on a total of 62,276 subjects. We used logistic regression models to investigate association between HCV infection and PD. The neurotoxicity of HCV was evaluated in the midbrain neuron-glia coculture system in rats. The cytokine/chemokine array was performed to measure the differences of amounts of cytokines released from midbrain in the presence and absence of HCV. The crude odds ratios (ORs) for having PD were 0.62 [95% confidence interval (CI), 0.48-0.81] and 1.91 (95% CI, 1.48-2.47) for hepatitis B virus (HBV) and HCV. After controlling for potential confounders, the association between HCV and PD remained statistically significant (adjusted OR = 1.39; 95% CI, 1.07-1.80), but not significantly different between HBV and PD. The HCV induced 60% dopaminergic neuron death in the midbrain neuron-glia coculture system in rats, similar to that of 1-methyl-4-phenylpyridinium (MPP(+) ) but not caused by HBV. This link was further supported by the finding that HCV infection may release the inflammatory cytokines, which may play a role in the pathogenesis of PD. In conclusion, our study demonstrated a significantly positive epidemiological association between HCV infection and PD and corroborated the dopaminergic toxicity of HCV similar to that of MPP(+) .
Keywords: Parkinson's disease; community; hepatitis C; neurotoxicity; risk factor.
© 2015 John Wiley & Sons Ltd.
Comment in
-
Hepatitis C virus infection: a risk factor for Parkinson's disease.J Viral Hepat. 2016 Jul;23(7):535. doi: 10.1111/jvh.12517. Epub 2016 Feb 23. J Viral Hepat. 2016. PMID: 26913500 No abstract available.
-
Re: Wangensteen et al. of a letter on 'Hepatitis C virus infection: a risk factor for Parkinson's disease.'.J Viral Hepat. 2016 Jul;23(7):560. doi: 10.1111/jvh.12521. Epub 2016 Feb 23. J Viral Hepat. 2016. PMID: 26913588 No abstract available.
Similar articles
-
Hepatitis B and C virus infection as a risk factor for Parkinson's disease in Israel-A nationwide cohort study.J Neurol Sci. 2019 Mar 15;398:138-141. doi: 10.1016/j.jns.2019.01.012. Epub 2019 Jan 11. J Neurol Sci. 2019. PMID: 30710864
-
Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort study.Neurology. 2016 Mar 1;86(9):840-6. doi: 10.1212/WNL.0000000000002307. Epub 2015 Dec 23. Neurology. 2016. PMID: 26701382
-
Association between viral hepatitis infection and Parkinson's disease: A population-based prospective study.J Viral Hepat. 2020 Nov;27(11):1171-1178. doi: 10.1111/jvh.13346. Epub 2020 Jul 10. J Viral Hepat. 2020. PMID: 32558154
-
Hepatitis C virus infection and risk of Parkinson's disease: a systematic review and meta-analysis.Eur J Gastroenterol Hepatol. 2018 Jan;30(1):9-13. doi: 10.1097/MEG.0000000000000991. Eur J Gastroenterol Hepatol. 2018. PMID: 29049127 Review.
-
Evidence for association between hepatitis C virus and Parkinson's disease.Neurol Sci. 2017 Nov;38(11):1913-1920. doi: 10.1007/s10072-017-3077-4. Epub 2017 Aug 5. Neurol Sci. 2017. PMID: 28780707 Review.
Cited by
-
Can infections trigger alpha-synucleinopathies?Prog Mol Biol Transl Sci. 2019;168:299-322. doi: 10.1016/bs.pmbts.2019.06.002. Epub 2019 Jul 3. Prog Mol Biol Transl Sci. 2019. PMID: 31699323 Free PMC article. Review.
-
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?Brain Sci. 2021 Dec 18;11(12):1654. doi: 10.3390/brainsci11121654. Brain Sci. 2021. PMID: 34942956 Free PMC article. Review.
-
Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?Metab Brain Dis. 2021 Jun;36(5):829-847. doi: 10.1007/s11011-021-00696-6. Epub 2021 Mar 11. Metab Brain Dis. 2021. PMID: 33704660 Review.
-
Impact of infection on risk of Parkinson's disease: a quantitative assessment of case-control and cohort studies.J Neurovirol. 2019 Apr;25(2):221-228. doi: 10.1007/s13365-018-0707-4. Epub 2019 Jan 10. J Neurovirol. 2019. PMID: 30632012
-
Emerging preclinical pharmacological targets for Parkinson's disease.Oncotarget. 2016 May 17;7(20):29835-63. doi: 10.18632/oncotarget.8104. Oncotarget. 2016. PMID: 26988916 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical